However, emerging analysis of CD4+CD25+CD127− and CD4+CD25+FOXP3+ cells suggest that the latter is a promising SLE activity indicator, especially in renal involvement, and may facilitate the detection of Treg subsets with clinical relevance [21]. The gene discussed is FOXP3; the disease is systemic lupus erythematosus.